Therefore, targeting UBR5 or UBR5-mediated CAPZA1 ubiquitination will provide promising strategies for preventing cancer metastasis in pancreatic cancer patients, particularly in those with high UBR5 expression. This evidence concerns the gene CAPZA1 and familial pancreatic carcinoma.